Detalhe da pesquisa
1.
Exploiting the tumor-suppressive activity of the androgen receptor by CDK4/6 inhibition in castration-resistant prostate cancer.
Mol Ther
; 30(4): 1628-1644, 2022 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35121110
2.
Androgen receptor splice variants drive castration-resistant prostate cancer metastasis by activating distinct transcriptional programs.
J Clin Invest
; 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687617
3.
LSD1 Inhibition Disrupts Super-Enhancer-Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate Cancer.
Cancer Res
; 83(10): 1684-1698, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36877164
4.
Demethylation of EHMT1/GLP Protein Reprograms Its Transcriptional Activity and Promotes Prostate Cancer Progression.
Cancer Res Commun
; 3(8): 1716-1730, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37663929
5.
RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibition.
Oncogene
; 41(6): 852-864, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34975152
6.
Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer.
Nat Genet
; 52(10): 1011-1017, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32868907
7.
LSD1 Activates PI3K/AKT Signaling Through Regulating p85 Expression in Prostate Cancer Cells.
Front Oncol
; 9: 721, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31428587
8.
TMPRSS2-ERG activates NO-cGMP signaling in prostate cancer cells.
Oncogene
; 38(22): 4397-4411, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30718921
9.
ZBTB7A Mediates the Transcriptional Repression Activity of the Androgen Receptor in Prostate Cancer.
Cancer Res
; 79(20): 5260-5271, 2019 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31444154
10.
A novel nonsense mutation in androgen receptor confers resistance to CYP17 inhibitor treatment in prostate cancer.
Oncotarget
; 8(4): 6796-6808, 2017 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28036278
11.
LSD1-Mediated Epigenetic Reprogramming Drives CENPE Expression and Prostate Cancer Progression.
Cancer Res
; 77(20): 5479-5490, 2017 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28916652
12.
Androgen Receptor Tumor Suppressor Function Is Mediated by Recruitment of Retinoblastoma Protein.
Cell Rep
; 17(4): 966-976, 2016 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-27760327
13.
ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer.
Clin Cancer Res
; 22(14): 3672-82, 2016 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26936914
14.
Forkhead domain mutations in FOXA1 drive prostate cancer progression.
Cell Res
; 29(9): 770-772, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31324883